Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas
暂无分享,去创建一个
[1] A. Giatromanolaki,et al. Tumour angiogenesis: vascular growth and survival , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[2] S. Kitano,et al. Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] S. Zucker,et al. Role of matrix metalloproteinases (MMPs) in colorectal cancer , 2004, Cancer and Metastasis Reviews.
[4] V. Catalano,et al. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] J. Melkko,et al. Inflammation and prognosis in colorectal cancer. , 2005, European journal of cancer.
[6] G. Nicolson,et al. Effects of mast cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor-derived and stromal fibroblasts , 2004, Clinical & Experimental Metastasis.
[7] Stephen J. Weiss,et al. Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.
[8] Xiao-Feng Sun,et al. Stromal staining for PINCH is an independent prognostic indicator in colorectal cancer. , 2004, Neoplasia.
[9] G. Bovo,et al. Pre-operative interleukin-2 immunotherapy induces eosinophilic infiltration in colorectal neoplastic stroma. , 1995, Pathologica.
[10] C. R. Teixeira,et al. Angiogenesis in advanced colorectal adenocarcinoma with special reference to tumoral invasion. , 2002, Arquivos de gastroenterologia.
[11] P. Hewett,et al. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma. , 2002, Cancer research.
[12] M. Tachibana,et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] G. Vrensen,et al. In Vivo Angiogenic Phenotype of Endothelial Cells and Pericytes Induced by Vascular Endothelial Growth Factor-A , 2004, Journal of Histochemistry and Cytochemistry.
[14] Yuan Li,et al. Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer. , 2005, Japanese journal of clinical oncology.
[15] Y. Fukushima,et al. Xenografts of human solid tumors frequently express cellular-associated isoform of vascular endothelial growth factor (VEGF) 189. , 1999, Oncology reports.
[16] D. Carbone,et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.
[17] K. Shirouzu,et al. The MMP-9 expression determined the efficacy of postoperative adjuvant chemotherapy using oral fluoropyrimidines in stage II or III colorectal cancer , 2006, Cancer Chemotherapy and Pharmacology.
[18] C. Turner,et al. Paxillin: a new vinculin-binding protein present in focal adhesions , 1990, The Journal of cell biology.
[19] M. Fernández-Aceñero,et al. Prognostic influence of tumor‐associated eosinophilic infiltrate in colorectal carcinoma , 2000, Cancer.
[20] K. Nabeshima,et al. Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. , 1999, The American journal of pathology.
[21] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[22] P. Chambon,et al. Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review , 2005, Breast Cancer Research and Treatment.
[23] K. Yano,et al. Matrix Metalloproteinase-7 Facilitates Insulin-Like Growth Factor Bioavailability through Its Proteinase Activity on Insulin-Like Growth Factor Binding Protein 3 , 2004, Cancer Research.
[24] K. O'Byrne,et al. Angiogenesis and the immune response as targets for the prevention and treatment of colorectal cancer (review). , 2003, Oncology reports.
[25] C. McArdle,et al. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer , 2005, British Journal of Cancer.
[26] M. A. Sáez,et al. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma , 1997, Cancer.
[27] R. Grenman,et al. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells , 2002, Oncogene.
[28] Hiroyuki Yamamoto,et al. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer. , 2003, Carcinogenesis.
[29] Stephen B Fox,et al. The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progression , 2003, The Journal of pathology.
[30] M. Cutler,et al. The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions. , 2005, Experimental cell research.
[31] M. Stolte,et al. A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum , 2001, Virchows Archiv.
[32] M. Zeitz,et al. Increased matrix metalloproteinase 2 concentration and transcript expression in advanced colorectal carcinomas , 2001, International Journal of Colorectal Disease.
[33] T. Ng,et al. A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[34] Paolo Bechi,et al. Character of the invasive margin in colorectal cancer , 1997, Diseases of the colon and rectum.
[35] G. Viale,et al. Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. , 1995, Cancer research.
[36] John E. Fothergill,et al. Matrix metalloproteinase–1 is associated with poor prognosis in colorectal cancer , 1996, Nature Medicine.
[37] L. Bretaudeau,et al. Induction of antigen presentation by macrophages after phagocytosis of tumour apoptotic cells. , 1998, Research in immunology.
[38] P. Böelle,et al. Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression , 2003, Virchows Archiv.
[39] E C Nice,et al. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF‐C/D receptor VEGFR‐3 , 2001, The EMBO journal.
[40] J. Folkman,et al. Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant Resistance* , 1999, The Journal of Biological Chemistry.
[41] H. Mellstedt,et al. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17‐1A , 2003, International journal of cancer.
[42] J. Guillem,et al. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[43] A. Schned,et al. Dendritic Cell Infiltration in Colon Cancer , 2001, Journal of immunotherapy.
[44] K. Chayama,et al. Clinical significance of angiogenesis in rectal carcinoid tumors. , 2002, Oncology reports.
[45] H. Höfler,et al. Stromelysin‐3 (ST‐3) mRNA Expression in Colorectal Carcinomas: Localization and Clinicopathologic Correlations , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[46] K. Burridge,et al. Focal adhesions, contractility, and signaling. , 1996, Annual review of cell and developmental biology.
[47] N. Minagawa,et al. Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer. , 2002, Anticancer research.
[48] Thomas Hawighorst,et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis , 2001, Nature Medicine.
[49] R. Flavell,et al. Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells , 2001, Nature Medicine.
[50] S. Miyagawa,et al. Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer. , 2004, Human pathology.
[51] G. Vrensen,et al. VEGFR‐3 in adult angiogenesis , 2001, The Journal of pathology.
[52] Marina Ziche,et al. VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant , 2004, Cancer Research.
[53] S. H. van der Burg,et al. Prognostic Value of Tumor-Infiltrating Dendritic Cells in Colorectal Cancer: Role of Maturation Status and Intratumoral Localization , 2005, Clinical Cancer Research.
[54] Van Blerk,et al. Lymphoid infiltration and prognosis in colorectal carcinoma , 1984, British Journal of Cancer.
[55] Y. Tu,et al. Nck-2, a novel Src homology2/3-containing adaptor protein that interacts with the LIM-only protein PINCH and components of growth factor receptor kinase-signaling pathways. , 1998, Molecular biology of the cell.
[56] E. Benjamini,et al. The immunoregulatory role of antigen-antibody complexes. I. Assessment of B and T-cell responses. , 1980, Immunology.
[57] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[58] J. Weyler,et al. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer , 1999, British Journal of Cancer.
[59] Steven A. Stacker,et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics , 2001, Nature Medicine.
[60] R. Altman,et al. Wild Type and Mutant p53 Differentially Regulate the Gene Expression of Human Collagenase-3 (hMMP-13)* , 2000, The Journal of Biological Chemistry.
[61] Xiao-Feng Sun,et al. Clinicopathological Significance of Stromelysin-3 Expression in Colorectal Cancer , 2004, Oncology.
[62] E. Ehler,et al. PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions. , 2003, Experimental cell research.
[63] P. Chambon,et al. Stromelysin-3 gene expression in human cancer: an overview. , 1994, Invasion & metastasis.
[64] R. Stenling,et al. Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors , 2002, International Journal of Colorectal Disease.
[65] J. Varani. Interaction of tumor cells with the extracellular matrix. , 1987, Revisiones sobre biologia celular : RBC.
[66] K. Hayashi,et al. Vascular Endothelial Growth Factor Messenger RNA Expression Level Is Preserved in Liver Metastases Compared with Corresponding Primary Colorectal Cancer , 2006, Clinical Cancer Research.
[67] Zhi-xiang Shen,et al. Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. , 2005, World journal of gastroenterology.
[68] Michihiko Yoshida,et al. A Novel Integrin-Linked Kinase–Binding Protein, Affixin, Is Involved in the Early Stage of Cell–Substrate Interaction , 2001, The Journal of cell biology.
[69] I. Nagtegaal,et al. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study , 2001, BMC Cancer.
[70] S. Hong,et al. Tumor Angiogenesis as a Prognostic Predictor in Colorectal Carcinoma with Special Reference to Mode of Metastasis and Recurrence , 1998, Oncology.
[71] N. Minagawa,et al. Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer. , 2003, Anticancer research.
[72] A. Kossakowska,et al. Expression Pattern of Metalloproteinases and Their Inhibitors Changes with the Progression of Human Sporadic Colorectal Neoplasia , 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[73] A. van den Hooff. Stromal involvement in malignant growth. , 1988, Advances in cancer research.
[74] T. Wobbes,et al. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients , 2004, International journal of cancer.
[75] R. Flavell,et al. Immune-Mediated Eradication of Tumors through the Blockade of Transforming Growth Factor-beta Signaling in T Cells , 2002 .
[76] O. Kockar,et al. Global Fibrinolytic Capacity Increased Exponentially in Metastatic Colorectal Cancer , 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[77] D. Carbone,et al. Erratum: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells (Nature Medicine 2, 1096-1103 (1996)) , 1996 .
[78] A. Harris,et al. Inclusion of Vasculature-Related Variables in the Dukes Staging System of Colon Cancer , 2005, Clinical Cancer Research.
[79] A. Rearden. A new LIM protein containing an autoepitope homologous to "senescent cell antigen". , 1994, Biochemical and biophysical research communications.
[80] T. Monden,et al. Use of fibrinogen to enhance the antitumor effect of OK‐432. A new approach to immunotherapy for colorectal carcinoma , 1992, Cancer.
[81] Yun Hua,et al. A New Focal Adhesion Protein That Interacts with Integrin-Linked Kinase and Regulates Cell Adhesion and Spreading , 2001, The Journal of cell biology.
[82] Y. Oshika,et al. © 1998 Cancer Research Campaign , 2022 .
[83] R. Steele,et al. Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. , 1998, British Journal of Cancer.
[84] X. Zhou,et al. Surgical treatment and late results in 1226 cases of colorectal cancer , 1983, Diseases of the colon and rectum.
[85] P. Basset,et al. Structure and Promoter Characterization of the Human Stromelysin-3 Gene (*) , 1995, The Journal of Biological Chemistry.
[86] S. Dedhar,et al. Inhibition of integrin linked kinase (ILK) suppresses β-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC−/− human colon carcinoma cells , 2001, Oncogene.
[87] J. Wood,et al. Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[88] G. Lip,et al. The hypercoagulable state of malignancy: pathogenesis and current debate. , 2002, Neoplasia.
[89] S. Pillai,et al. Innate immunity. , 1996, Current opinion in immunology.
[90] K. Okita,et al. Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer. , 2004, Gastrointestinal endoscopy.
[91] P. Basset,et al. Assignment of the human stromelysin 3 (STMY3) gene to the q11.2 region of chromosome 22. , 1992, Genomics.
[92] H. Saito,et al. Effects of super-extended paraaortic lymphadenectomy (PAL) on biological responses in totally gastrectomized patients with T3 or T4 gastric cancer , 1998, Gastric Cancer.
[93] I. Talbot,et al. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. , 1996, Cancer research.
[94] H. Spjut,et al. Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma , 1967, Cancer.
[95] S. Leurgans,et al. Tumor Angiogenesis as a Predictor of Recurrence and Survival in Patients with Node‐Negative Colon Cancer , 1995, Annals of surgery.
[96] C. McArdle,et al. Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[97] T. Bauer,et al. Ki‐67‐determined growth fraction versus standard staging and grading parameters in colorectal carcinoma: A multivariate analysis , 1992, Cancer.
[98] Y. Maehara,et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues , 2000, British Journal of Cancer.
[99] R. Schwendener,et al. Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy. , 2006, Cancer letters.
[100] K. Chayama,et al. Clinical Significance of Vascular Endothelial Growth Factor C Expression and Angiogenesis at the Deepest Invasive Site of Advanced Colorectal Carcinoma , 2002, Oncology.
[101] L. Devy,et al. Emerging roles for proteinases in cancer. , 1997, Invasion & metastasis.
[102] D. Murray,et al. Prognosis in colon cancer: a pathologic reassessment. , 1975, Archives of surgery.
[103] S. Kawasaki,et al. Morphometric analysis of liver macrophages in patients with colorectal liver metastasis , 2004, Clinical & Experimental Metastasis.
[104] Z. Werb,et al. ECM signalling: orchestrating cell behaviour and misbehaviour. , 1998, Trends in cell biology.
[105] B. Yasar,et al. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[106] Lida Guo,et al. Regulation of fibronectin matrix deposition and cell proliferation by the PINCH‐ILK‐CH‐ILKBP complex , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[107] Y. Tu,et al. The LIM-Only Protein PINCH Directly Interacts with Integrin-Linked Kinase and Is Recruited to Integrin-Rich Sites in Spreading Cells , 1999, Molecular and Cellular Biology.
[108] Hong Zhang,et al. Relationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers. , 2005, World journal of gastroenterology.
[109] M. Langenskiöld,et al. Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer , 2005, International Journal of Colorectal Disease.
[110] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[111] V. Kosma,et al. Prognostic value of tumour‐infiltrating lymphocytes (TILs) in colorectal cancer , 1997, The Journal of pathology.
[112] F. O'Malley,et al. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. , 1996, The American journal of surgical pathology.
[113] S. Kumar,et al. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis , 2003, British Journal of Cancer.
[114] I. Okayasu,et al. Enzyme histochemical analysis of lymphatic vessels in colon carcinoma: occurrence of lymphangiogenesis within the tumor. , 2005, Hepato-gastroenterology.
[115] A. Giatromanolaki,et al. “Stromatogenesis” and Tumor Progression , 2004, International journal of surgical pathology.
[116] W. Schürch,et al. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[117] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.
[118] B. C. Patterson,et al. Angiostatin-converting Enzyme Activities of Human Matrilysin (MMP-7) and Gelatinase B/Type IV Collagenase (MMP-9)* , 1997, The Journal of Biological Chemistry.
[119] Meera Mathur,et al. Stromelysin‐3 expression is an early event in human oral tumorigenesis , 2003, International journal of cancer.
[120] K. Chayama,et al. Clinical Significance of Angiogenic Factor Expression at the Deepest Invasive Site of Advanced Colorectal Carcinoma , 2002, Oncology.
[121] Scott Kurtzman,et al. Angiogenesis in normal tissue adjacent to colon cancer , 1998, Journal of surgical oncology.
[122] A. Wellmann,et al. Stromal expression of invasion‐promoting, matrix‐degrading proteases MMP‐1 and ‐9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers , 2003, International journal of cancer.
[123] P. Gold. Immunology and immunotherapy of colorectal cancer. , 1978, Canadian journal of surgery. Journal canadien de chirurgie.
[124] C. Sautès-Fridman,et al. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. , 2001, Cancer research.
[125] E. Roeb,et al. Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas , 2004, International Journal of Colorectal Disease.
[126] J. Marshall,et al. A Phase I Study of Oral BMS-275291, a Novel Nonhydroxamate Sheddase-Sparing Matrix Metalloproteinase Inhibitor, in Patients with Advanced or Metastatic Cancer , 2004, Clinical Cancer Research.
[127] M. Pollán,et al. Histopathologic prognostic score in colorectal adenocarcinomas. , 1998, Anticancer Research.
[128] Gary Ruvkun,et al. A Conserved LIM Protein That Affects Muscular Adherens Junction Integrity and Mechanosensory Function in Caenorhabditis elegans , 1999, The Journal of cell biology.
[129] L. Jurata,et al. Structure and function of LIM domains. , 1998, Current topics in microbiology and immunology.
[130] M. Heymann,et al. Immunomodulatory effects of tumor‐associated fibroblasts in colorectal‐tumor development , 1999, International journal of cancer.
[131] B. Bussolati,et al. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. , 2001, The American journal of pathology.
[132] J. Wang-Rodriguez,et al. The signaling adapter protein PINCH is up‐regulated in the stroma of common cancers, notably at invasive edges , 2002, Cancer.
[133] A. Mori,et al. Absence of Smooth Muscle Actin-Positive Pericyte Coverage of Tumor Vessels Correlates with Hematogenous Metastasis and Prognosis of Colorectal Cancer Patients , 2005, Oncology.
[134] M. Enjoji,et al. Histopathologic evaluation of survival time in patients with colorectal carcinoma , 1989, Journal of surgical oncology.
[135] K. Saito,et al. Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer: a possible antitumor immunity? , 1997, Laboratory investigation; a journal of technical methods and pathology.
[136] M. Fernández-Aceñero,et al. Prognostic significance of microvascular counts in rectal carcinoma. , 2000, Pathology, research and practice.
[137] E. Bergsland. Vascular endothelial growth factor as a therapeutic target in cancer. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[138] S. Eccles,et al. VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression. , 2001, Neoplasia.
[139] R. Longo,et al. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. , 1998, British Journal of Cancer.
[140] Y. Tu,et al. Distinct Roles of Two Structurally Closely Related Focal Adhesion Proteins, α-Parvins and β-Parvins, in Regulation of Cell Morphology and Survival* , 2004, Journal of Biological Chemistry.
[141] J. Jass. Lymphocytic infiltration and survival in rectal cancer. , 1986, Journal of clinical pathology.
[142] Xiao-Feng Sun,et al. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy. , 2006, International journal of radiation oncology, biology, physics.
[143] K. Rubin,et al. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage. , 1997, British Journal of Cancer.
[144] Christopher J. Robinson,et al. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. , 2001, Journal of cell science.
[145] S. Dedhar,et al. Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase , 1996, Nature.
[146] M. Mori,et al. S‐100 protein‐positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis , 1989, Cancer.
[147] W. Hohenberger,et al. Angiogenesis and dendritic cell density are not correlated with metachronous distant metastasis in curatively operated rectal cancer , 2003, International Journal of Colorectal Disease.
[148] Lida Guo,et al. A Critical Role of the PINCH-Integrin-linked Kinase Interaction in the Regulation of Cell Shape Change and Migration* , 2002, The Journal of Biological Chemistry.
[149] S. Akiba,et al. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma , 1996, Cancer.
[150] K. Chayama,et al. Expression of VEGF‐C and VEGF‐D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma , 2004, Cancer science.
[151] Masaichi Ogawa,et al. Expression of matrix metalloproteinase 7, laminin and type IV collagen-associated liver metastasis in human colorectal cancer: immunohistochemical approach. , 2005, Hepato-gastroenterology.
[152] R. Laing,et al. Feasibility of new prognostic classification for rectal cancer. , 1988, Journal of clinical pathology.
[153] Rakesh K Jain,et al. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. , 2002, The American journal of pathology.
[154] R. Whitehouse,et al. Tumor angiogenesis in stage II colorectal carcinoma: association with survival. , 1998, American journal of clinical pathology.
[155] S. Arii,et al. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma , 2000, Cancer.
[156] H. Nielsen,et al. Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue , 1999, The Journal of pathology.
[157] H. Denk,et al. Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer , 2004, Virchows Archiv.
[158] M. J. Fernández Aceñero,et al. Vascular enumeration as a prognosticator for colorectal carcinoma. , 2000, European journal of cancer.
[159] W. Stetler-Stevenson,et al. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. , 1996, Seminars in cancer biology.
[160] 宮本 心一. Matrix metalloproteinase-7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein-3 , 2004 .
[161] J. Harmey,et al. Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF) , 2005, Journal of cellular and molecular medicine.
[162] Y. Atomi,et al. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas , 2001, British Journal of Cancer.
[163] N. Brown,et al. Proteolysis in colorectal cancer. , 1999, Molecular pathology : MP.
[164] M. Yamakawa,et al. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma , 2002, The Journal of pathology.
[165] P. Mingazzini,et al. The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients. , 1992, International surgery.
[166] A. Jubb,et al. Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[167] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[168] A. Khorana,et al. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma , 2003, Cancer.
[169] J. Burke,et al. Fine structure of the lymphatic capillary and the adjoining connective tissue area. , 1966, The American journal of anatomy.
[170] K. Yoshimura,et al. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection , 2003, Journal of surgical oncology.
[171] N. Minagawa,et al. Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancer. , 2005, Anticancer research.
[172] S. Takeno,et al. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. , 2003, Oncology reports.
[173] F. Cianchi,et al. Tumor angiogenesis in lymph node-negative rectal cancer: Correlation with clinicopathological parameters and prognosis , 2002, Annals of Surgical Oncology.
[174] C. Miki,et al. Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma , 2000, American Journal of Gastroenterology.
[175] Rakesh K Jain,et al. Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics , 2002, Science.
[176] R. Tollenaar,et al. Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells , 2004, Cancer Immunology, Immunotherapy.
[177] J. J. Breen,et al. LIM domains: multiple roles as adapters and functional modifiers in protein interactions. , 1998, Trends in genetics : TIG.
[178] W. Jiang,et al. Prognostic values of tumor endothelial markers in patients with colorectal cancer. , 2005, World journal of gastroenterology.
[179] E. Thorsby,et al. p21‐ras‐peptide‐specific T‐cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp) , 2007, International journal of cancer.
[180] C. Meininger. Mast cells and tumor-associated angiogenesis. , 1995, Chemical immunology.
[181] Jian-ping Wang,et al. [Correlation of lymphangiogenesis to progression of colorectal cancer]. , 2005, Ai zheng = Aizheng = Chinese journal of cancer.
[182] W. Jiang,et al. Quantitative analysis of lymphangiogenic markers in human colorectal cancer. , 2003, International journal of oncology.
[183] M. Koutsilieris,et al. Mast cell-tumor cell interactions: for or against tumour growth and metastasis? , 1997, Anticancer research.
[184] Y. Tu,et al. Distinct roles of two structurally closely related focal adhesion proteins, alpha-parvins and beta-parvins, in regulation of cell morphology and survival. , 2004, The Journal of biological chemistry.
[185] S. Chakraborti,et al. Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.
[186] B. Bodey,et al. Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas. , 2000, In Vivo.
[187] S. Dedhar,et al. Integrin-linked Protein Kinase Regulates Fibronectin Matrix Assembly, E-cadherin Expression, and Tumorigenicity* , 1998, The Journal of Biological Chemistry.
[188] L. Ellis,et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. , 1995, Cancer research.
[189] A. Parker,et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. , 2004, Arthritis and rheumatism.
[190] P. Chambon,et al. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin‐3 and BM‐40/SPARC genes , 1995, International journal of cancer.
[191] M. Barbacid,et al. Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3* , 1997, The Journal of Biological Chemistry.
[192] M. D. Della Porta,et al. Dendritic Cells and Vascular Endothelial Growth Factor in Colorectal Cancer: Correlations with Clinicobiological Findings , 2005, Oncology.
[193] G. Jayson,et al. Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy , 2003, British Journal of Cancer.
[194] D. Leaper,et al. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging , 2000, The British journal of surgery.
[195] A. Harris,et al. Combined role of tumor angiogenesis, bcl‐2, and p53 expression in the prognosis of patients with colorectal carcinoma , 1999, Cancer.
[196] E. Chinelli,et al. Prognostic correlations of operable carcinoma of the rectum , 1985, Diseases of the Colon & Rectum.
[197] A. House,et al. Colonic carcinoma. A quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis , 1978, Cancer.
[198] H. Ohtani,et al. Close Association between Fas Ligand (FasL; CD95L)‐positive Tumor‐associated Macrophages and Apoptotic Cancer Cells along Invasive Margin of Colorectal Carcinoma: A Proposal on Tumor‐Host Interactions , 2002, Japanese journal of cancer research : Gann.
[199] M. Mandalà,et al. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. , 2001, Journal of biological regulators and homeostatic agents.
[200] A. Küpelioğlu,et al. Matrix metalloproteinase‐9,‐3 and tissue inhibitor of matrix metalloproteinase‐1 in colorectal cancer: relationship to clinicopathological variables , 2007, Cell biochemistry and function.
[201] K. Ikari,et al. Matrix metalloproteinase 28/epilysin expression in cartilage from patients with rheumatoid arthritis and osteoarthritis: comment on the article by Kevorkian et al. , 2004, Arthritis and rheumatism.
[202] Meit A. Björndahl. Lymphangiogenesis and lymphatic metastasis , 2005 .
[203] J. Gille. Antiangiogenic cancer therapies get their act together: current developments and future prospects of growth factor‐ and growth factor receptor‐targeted approaches , 2006, Experimental dermatology.
[204] J. Sloan,et al. A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin , 2005, Anti-cancer drugs.
[205] C. López-Otín,et al. Differential Expression of Three Matrix Metalloproteinases, MMP-19, MMP-26, and MMP-28, in Normal and Inflamed Intestine and Colon Cancer , 2004, Digestive Diseases and Sciences.
[206] H. Putter,et al. Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis , 2004, Laboratory Investigation.
[207] H. Ohtani,et al. Stromal Expression of MMP‐9 and Urokinase Receptor Is Inversely Associated with Liver Metastasis and with Infiltrating Growth in Human Colorectal Cancer: A Novel Approach from Immune/Inflammatory Aspect , 1997, Japanese journal of cancer research : Gann.
[208] Lida Guo,et al. Characterization of PINCH-2, a New Focal Adhesion Protein That Regulates the PINCH-1-ILK Interaction, Cell Spreading, and Migration* , 2002, The Journal of Biological Chemistry.
[209] S. Leung,et al. Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon. , 1998, Human pathology.
[210] H. Höfler,et al. Stromelysin-3 expression in early (pT1) carcinomas and pseudoinvasive lesions of the colorectum , 1997, Virchows Archiv.
[211] Z. Werb,et al. How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.
[212] M. Oya,et al. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. , 2001, Japanese journal of clinical oncology.
[213] J. McKay,et al. Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer , 2002, Journal of clinical pathology.
[214] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[215] G. Karakiulakis,et al. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon. , 1997, Invasion & metastasis.
[216] R. Gausas,et al. Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. , 2004, Oncology reports.
[217] R. vander Zwaag,et al. From Dukes through Jass: pathological prognostic indicators in rectal cancer. , 1994, Human pathology.